Israel Englander Reviva Pharmaceuticals Holdings, Inc. Call Options Transaction History

Millennium Management LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q4 2023 Feb 14, 2024	SELL	$3.56 - $6.04 $161,980 - $274,820	-45,500 Reduced 45.5%	54,500 $280,000
Q2 2023 Aug 14, 2023	BUY	$4.42 - $8.55 $442,000 - $855,000	100,000 New	100,000 $586,000

6.77M

256K

77.1K

Ticker RVPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,442,900
Market Cap $19.4M
Description
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.